Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005794 | Golgi apparatus | 5 | 3 |
GO:0016020 | membrane | 2 | 14 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
Related structures:
AlphaFold database: Q4Q436
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.499 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.303 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.392 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 202 | 204 | PF00675 | 0.298 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.299 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.298 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.392 |
CLV_PCSK_KEX2_1 | 194 | 196 | PF00082 | 0.326 |
CLV_PCSK_KEX2_1 | 202 | 204 | PF00082 | 0.298 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.302 |
CLV_PCSK_PC1ET2_1 | 194 | 196 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.281 |
CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.357 |
CLV_Separin_Metazoa | 20 | 24 | PF03568 | 0.469 |
DEG_APCC_DBOX_1 | 120 | 128 | PF00400 | 0.281 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.615 |
DOC_MAPK_gen_1 | 118 | 128 | PF00069 | 0.169 |
DOC_MAPK_gen_1 | 98 | 107 | PF00069 | 0.586 |
DOC_MAPK_MEF2A_6 | 121 | 128 | PF00069 | 0.366 |
DOC_PP1_RVXF_1 | 119 | 126 | PF00149 | 0.299 |
DOC_PP1_RVXF_1 | 24 | 31 | PF00149 | 0.469 |
DOC_PP2B_LxvP_1 | 34 | 37 | PF13499 | 0.503 |
DOC_USP7_UBL2_3 | 153 | 157 | PF12436 | 0.577 |
DOC_USP7_UBL2_3 | 78 | 82 | PF12436 | 0.550 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.269 |
LIG_Actin_RPEL_3 | 93 | 112 | PF02755 | 0.469 |
LIG_EH1_1 | 61 | 69 | PF00400 | 0.487 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.347 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.577 |
LIG_GBD_Chelix_1 | 106 | 114 | PF00786 | 0.348 |
LIG_LIR_Gen_1 | 11 | 21 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 122 | 133 | PF02991 | 0.396 |
LIG_LIR_Gen_1 | 40 | 50 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 11 | 16 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 122 | 128 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 40 | 46 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 60 | 65 | PF02991 | 0.274 |
LIG_NRBOX | 101 | 107 | PF00104 | 0.440 |
LIG_NRBOX | 109 | 115 | PF00104 | 0.366 |
LIG_NRBOX | 119 | 125 | PF00104 | 0.213 |
LIG_Pex14_1 | 9 | 13 | PF04695 | 0.480 |
LIG_PTB_Apo_2 | 56 | 63 | PF02174 | 0.380 |
LIG_REV1ctd_RIR_1 | 114 | 122 | PF16727 | 0.197 |
LIG_SH2_CRK | 99 | 103 | PF00017 | 0.486 |
LIG_SH2_PTP2 | 43 | 46 | PF00017 | 0.345 |
LIG_SH2_SRC | 172 | 175 | PF00017 | 0.629 |
LIG_SH2_SRC | 43 | 46 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 161 | 165 | PF00017 | 0.573 |
LIG_SH2_STAP1 | 39 | 43 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 145 | 148 | PF00017 | 0.603 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.608 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.339 |
LIG_SH3_3 | 47 | 53 | PF00018 | 0.383 |
LIG_SUMO_SIM_anti_2 | 66 | 72 | PF11976 | 0.424 |
LIG_SUMO_SIM_anti_2 | 88 | 94 | PF11976 | 0.540 |
LIG_SUMO_SIM_par_1 | 69 | 75 | PF11976 | 0.415 |
LIG_TYR_ITIM | 97 | 102 | PF00017 | 0.485 |
LIG_UBA3_1 | 112 | 118 | PF00899 | 0.197 |
LIG_UBA3_1 | 70 | 78 | PF00899 | 0.351 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.615 |
MOD_Cter_Amidation | 93 | 96 | PF01082 | 0.209 |
MOD_GlcNHglycan | 176 | 180 | PF01048 | 0.286 |
MOD_N-GLC_2 | 130 | 132 | PF02516 | 0.351 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.327 |
MOD_PKA_1 | 141 | 147 | PF00069 | 0.563 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.594 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.424 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.575 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.269 |
MOD_SUMO_rev_2 | 190 | 196 | PF00179 | 0.584 |
TRG_DiLeu_BaLyEn_6 | 50 | 55 | PF01217 | 0.351 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.500 |
TRG_ER_diArg_1 | 193 | 196 | PF00400 | 0.587 |
TRG_ER_diArg_1 | 95 | 98 | PF00400 | 0.502 |
TRG_NLS_MonoExtC_3 | 79 | 85 | PF00514 | 0.469 |
TRG_NLS_MonoExtN_4 | 78 | 84 | PF00514 | 0.533 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JEM7 | Bodo saltans | 26% | 99% |
A0A1X0P100 | Trypanosomatidae | 44% | 78% |
A0A3Q8IK58 | Leishmania donovani | 91% | 100% |
A0A3S7X6T0 | Leishmania donovani | 26% | 100% |
A0A422NG43 | Trypanosoma rangeli | 40% | 70% |
A4HLL2 | Leishmania braziliensis | 80% | 100% |
A4I924 | Leishmania infantum | 26% | 100% |
D0A526 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 91% |
E9AHN5 | Leishmania infantum | 91% | 100% |
E9B3Y8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
E9B3Y9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
Q4Q435 | Leishmania major | 26% | 100% |